Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 451 AL 465

Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study

Povala G, Bellaver B, Lussier FZ, Amaral L, Bauer-Negrini G, Ferreira PCL, Rocha A, Ruppert E, Medeiros MS, Tissot C, Jagust WJ, Masdeu JC, Fortea J, Tudorascu DL, Soleimani-Meigooni DN, Lowe V, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker S, Pascoal TA; HEAD Study.

Lancet. 2026 May 30;407(10544):2217-2226. doi: 10.1016/S0140-6736(26)00417-4.

Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial

Kim MG, Woo SH, Kim GW, Choi HK, Kim KK, Koo BS.

J Alzheimers Dis. 2026 May;111(1):397-409. doi: 10.1177/13872877261431692. Epub 2026 Mar 16.

Phase II clinical trial of KCHO-1 for Alzheimer's disease: study protocol for a multicenter, randomized, double-blind, multi-dose, placebo trial

Shin J, Jeong TS, Jung HS, Kim D, Kim CH, Yi S, Kang HW, Han D, Kim S.

Trials. 2026 Feb 26;27(1):266. doi: 10.1186/s13063-026-09572-z.

Older Adults, Anti-Amyloid Therapy, and Frailty: What Oncology Can Teach Us

Borda MG, O'Hara-Veintimilla K, Aarsland D.

Eur J Neurol. 2026 Apr;33(4):e70567. doi: 10.1111/ene.70567.

Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup

van Etten ES, Mahinrad S, Grill JD, Salloway S, Atri A, Cogswell PM, Benzinger TLS, Iwatsubo T, Iadecola C, Lemere CA, Nicoll JAR, Greenberg SM, Carrillo MC, Jack CR Jr, Sperling RA.

Alzheimers Dement. 2026 Apr;22(4):e71361. doi: 10.1002/alz.71361.

Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer's Disease and Cerebral Amyloid Angiopathy

Zedde M, Losa M, Grisafi E, Lucia DD, Gandoglia I, Del Sette M, Pardini M, Roccatagliata L, Pascarella R, Piazza F.

Biomolecules. 2026 Jan 5;16(1):89. doi: 10.3390/biom16010089.

Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial

Kong X, Han R, Fan X, Wei K, Ma Z, Yang G, Zhao Y, Yang Y, Yang Y, Hong J, Liu J, Zhang D, Ma X.

J Alzheimers Dis. 2026 May;111(2):757-767. doi: 10.1177/13872877261435880. Epub 2026 Mar 30.

[New treatments for Alzheimer disease : A challenge for radiology]

Haußmann A.

Radiologie (Heidelb). 2026 Apr;66(4):249-257. doi: 10.1007/s00117-026-01560-3. Epub 2026 Jan 29.

Comparative effects of some pharmacological and non-pharmacological interventions on cognitive function in Alzheimer's disease: A Bayesian network meta-analysis

Zhao Y, Luo G, Huang C, Chen Z, Wei Y, Chen Q, Wang F, Gan Y, Yin X.

J Prev Alzheimers Dis. 2026 Jun;13(6):100564. doi: 10.1016/j.tjpad.2026.100564. Epub 2026 Apr 11.

The value and risks of antidepressant therapy in Alzheimer's disease: a field update and its clinical implications

Rus Prelog P, Kores Plesničar B, Zupan M, Frol S, Kramberger MG.

Expert Rev Neurother. 2026 Jun;26(6):523-537. doi: 10.1080/14737175.2026.2653170. Epub 2026 Apr 6.

Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies

Mathoux G, Harput E, Peretti DE, Boccalini C, Garibotto V.

Curr Opin Neurol. 2026 Apr 1;39(2):161-167. doi: 10.1097/WCO.0000000000001471. Epub 2026 Feb 19.

Efficacy and Safety of Tsumura Ninjin'yoeito for Loss of Appetite and Apathy in Patients With Alzheimer's Disease or Dementia With Lewy Bodies: A Multicentre, Open-Label, Randomised, Comparative Study

Tamura M, Shindo T, Okahara K, Fukasawa T, Asada T, Jinnouchi T, Ohsawa M, Furukawa K, Sato H, Higuchi MA, Ikeda K, Suzuki K, Uemura K, Arai T.

Psychogeriatrics. 2026 Jan;26(1):e70120. doi: 10.1111/psyg.70120.

Lecanemab treatment for mild alzheimer's disease with high risk of cerebral hemorrhage: a case report

Tian Q, Liu M, Zhong F, Liu X, Lü Y.

BMC Neurol. 2026 Jan 9;26(1):76. doi: 10.1186/s12883-025-04581-y.

Psychopharmacotherapy of Alzheimer's Disease-What Do We Have at Hand?

Naguy A, Pridmore S, Singh A, Solanki A.

Psychopharmacol Bull. 2026 Mar 11;56(2):170-175. doi: 10.64719/pb.16605.

The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies

Chiotis K, Wang Y, La Joie R, Rabinovici GD.

J Nucl Med. 2026 Feb 2;67(2):175-185. doi: 10.2967/jnumed.124.268339.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias